E ENDEAVOR HEALTH
DEAD

Serial Number

98161235

Owner

Edward-Elmhurst Healthcare

Attorney

Andrew L. Goldstein

Filing Date

Sep 1, 2023

Add to watchlist:

No watchlists yet
View on USPTO

E ENDEAVOR HEALTH Trademark

Serial Number: 98161235

E ENDEAVOR HEALTH is a trademark filed by Edward-Elmhurst Healthcare on September 1, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 36 (Insurance & Financial), Class 38 (Telecommunications), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Edward-Elmhurst Healthcare (29 trademarks)

Naperville, IL 60540

Entity Type: 03

Trademark Details

Filing Date

September 1, 2023

Registration Date

Not Registered

Goods & Services

Educational services, namely, providing courses of instruction in the field of medicine and healthcare through a medical school and providing continuing medical education courses; fitness center services, namely, providing fitness and exercise facilities

Genomic tests composed primarily of reagents for medical or clinical purposes; genomic tests for analyzing DNA information composed primarily of reagents for medical or clinical purposes; kits composed of reagents for use in genetic testing for medical or clinical purposes

Providing access to databases that enable users to access patient diagnostic health information, medical reports, and educational information in the area of medicine

Charitable fundraising services in the field of medicine

Providing referrals in the field of physician services; retail pharmacy services

Organizing and conducting support groups relating to health issues

Medical and health care services offered in hospital, ambulatory and outpatient settings, namely, hospital services, medical clinic services, medical clinics, physician services, home health care and hospice services, immediate and urgent medical care services, medical testing services for diagnostic or treatment purposes, and nursing care services; provision of home healthcare services; hospital and healthcare services; managed health care services; medical services; medical clinics; medical counseling services; providing medical profile and medical record analysis and assessments for diagnostic purposes; genetic testing for medical purposes; providing medical information, consultancy, and advisory services; preparation and generation of reports for medical diagnostic testing services, namely, medical diagnostic testing, monitoring and reporting services; pharmacogenomics testing for diagnostic or treatment services; addiction treatment services in the field of substance abuse; psychiatric services; medical services in the field of surgery; diagnostic and therapeutic radiology services; organ transplant services, namely, medical services; conducting sleep studies for medical diagnostic and treatment purposes and healthcare services, namely, treatment of sleep disorders; medical care with respect to pain management treatment; providing an internet website portal in the field of medical and healthcare services

Medical and scientific research, namely, conducting clinical trials for others; Translational research, namely, medical research involving the translation of findings in scientific research to medical practice; providing scientific analysis and scientific research consulting in the fields of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and to assess risks associated with certain diseases; consulting in the field of laboratory research to report on the results of laboratory testing in the field of genetics, genomics, DNA testing, genetic testing, genetic screening, genotyping, phenotyping, molecular analytics, pharmacogenomics, and assessing risks associated with certain diseases; medical laboratory services

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Oct 18, 2024 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Oct 18, 2024 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jul 2, 2024 GNRN
NON-FINAL ACTION E-MAILED
Jul 2, 2024 GNRT
NON-FINAL ACTION WRITTEN
Jul 2, 2024 CNRT
LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN
Jul 2, 2024 LOPE
LETTER OF PROTEST EVIDENCE FORWARDED
Apr 17, 2024 LOPT
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Feb 27, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Feb 27, 2024 GNSL
SUSPENSION LETTER WRITTEN
Feb 27, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 23, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 23, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 23, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 21, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 21, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2023 NWOS
NEW APPLICATION ENTERED
Sep 5, 2023 NWAP